← Back to Search
Coumarin Derivatives As Potential Antitumor Agents: Growth Inhibition, Apoptosis Induction And Multidrug Resistance Reverting Activity.
A. Bisi, C. Cappadone, A. Rampa, G. Farruggia, A. Sargenti, F. Belluti, R. D. Di Martino, E. Malucelli, A. Meluzzi, S. Iotti, S. Gobbi
Published 2017 · Chemistry, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
A small library of coumarins, carrying butynyl-amino chains, was synthesized continuing our studies in the field of MDR reverting ageEnts and in order to obtain multipotent agents to combat malignancies. In particular, the reported anticancer and chemopreventive natural product 7-isopentenyloxycoumarin was linked to different terminal amines, selected on the basis of our previously reported results. The anticancer behaviour and the MDR reverting ability of the new compounds were evaluated on human colon cancer cells, particularly prone to develop the MDR phenotype. Some of the new derivatives showed promising effects, directly acting as cytotoxic compounds and/or counteracting MDR phenomenon. Compound 1e emerged as the most interesting of this series, showing a multipotent biological profile and suggesting that conjugation of an appropriate coumarin core with a properly selected butynyl-amino chain allows to obtain novel hybrid molecules endowed with improved in vitro antitumor activity.
This paper references
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin.
M. Grandi (1986)
Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
A. Dantzig (1996)
Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.
T. Litman (1997)
Kinetics of the multidrug transporter (P-glycoprotein) and its reversal.
W. Stein (1997)
Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
M. Fanciulli (2000)
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
P. Mistry (2001)
The biochemistry and medical significance of the flavonoids.
B. Havsteen (2002)
Studies on cancer chemoprevention by traditional folk medicines XXIV. Inhibitory effect of a coumarin derivative, 7-isopentenyloxycoumarin, against tumor-promotion.
M. Baba (2002)
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance
B. Hill (2004)
Transporters and drug therapy: Implications for drug disposition and disease
R. Ho (2005)
The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines
R. B. Myers (2005)
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis.
A. Andreani (2007)
Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
A. Bisi (2008)
Insights on Novel Biologically Active Natural Products: 7-Isopentenyloxycoumarin
F. Epifano (2009)
ABC pumps and their role in active drug transport.
N. Colabufo (2009)
Cytotoxicity of methoctramine and methoctramine-related polyamines.
M. Zini (2009)
Membrane transporters in drug development
K. Giacomini (2010)
Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells.
Regine Lüpertz (2010)
Coumarins: old compounds with novel promising therapeutic perspectives.
M. Riveiro (2010)
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
C. Bruyère (2011)
Three decades of P-gp inhibitors: skimming through several generations and scaffolds.
A. Palmeira (2012)
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
O. Wesołowska (2012)
Collateral sensitivity as a strategy against cancer multidrug resistance.
Kristen M Pluchino (2012)
Sigma‐2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral Sensitivity
M. Niso (2013)
Current developments of coumarin compounds in medicinal chemistry.
Xin-Mei Peng (2013)
The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage
F. Haghighi (2013)
Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel.
K. Lee (2014)
Small and Innovative Molecules as New Strategy to Revert MDR
Laura Zinzi (2014)
Coumarin hybrids as novel therapeutic agents.
Sonali Sandhu (2014)
Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold.
A. Bisi (2015)
Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin
S. Castiglioni (2015)
Mannich bases in medicinal chemistry and drug design
G. Roman (2015)
Advances in plant-based inhibitors of P-glycoprotein
Jun Yu (2016)
This paper is referenced by
Optical properties of solute molecules: Environmental effects, challenges, and their practical implications
M. Homocianu (2021)
Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer.
Avijit Ghosh (2021)
Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
Saad Alghamdi (2020)
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
Manish Kumar (2020)
7-Isopentenyloxycoumarin: What Is New across the Last Decade
Francesca Preziuso (2020)
Ce(IV) immobilized on halloysite nanotube–functionalized dendrimer (Ce(IV)–G2): A novel and efficient dendritic catalyst for the synthesis of pyrido[3,2‐ c ]coumarin derivatives
Tahereh Ataee-Kachouei (2020)
Synthesis and antioxidant properties of some new thiazolyl coumarin derivatives
D. Bensalah (2020)
Natural Products as Chemosensitizers for Adjunct Therapy in Cancer Management
Suchisnigdha Datta (2020)
Recent advancements of coumarin-based anticancer agents: An up-to-date review.
T. Al-Warhi (2020)
Cytotoxic Effects of Hydroxy Coumarin Derivatives on Mouse Neuroblastoma N2a Cell Line
J. Sargolzaei (2020)
Experimental and DFT/TD-DFT computational investigations of the solvent effect on the spectral properties of nitro substituted pyridino[3,4-c]coumarins
M. Shkoor (2020)
Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
M. Majidinia (2020)
New nanodrug design for cancer therapy: Its synthesis, formulation, in vitro and in silico evaluations
Yasemin Budama-Kilinc (2020)
Bis(4-hydroxy-2H-chromen-2-one) Coumarin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Aromatase Inhibition
L. H. Ramdani (2019)
Synthesis, characterization and antitumor activity of novel ferrocene-coumarin conjugates
Jing-Na Wei (2019)
Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
H. Dai (2019)
Facile and Green One‐Pot Synthesis of Fluorophore Chromeno[4,3‐b]quinolin‐6‐one Derivatives Catalyzed by Halloysite Nanoclay under Solvent‐free Conditions
Tahereh Ataee-Kachouei (2019)
Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5
J. Sachs (2019)
Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents.
Yu Wang (2019)
Concentration and distribution of silica nanoparticles in colon cancer cells assessed by synchrotron based X-ray techniques.
Alessandra Procopio (2019)
Click synthesis of N1-(β-D-ribofuranosyl)-C4-(coumarin-4″-yl)-1,2,3-triazoles
Vipin K. Maikhuri (2019)
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy
T. Khomenko (2019)
Hybrids of Coumarin Derivatives as potent and multifunctional bioactive agents: A review.
Ioannis Fotopoulos (2019)
Oxa/thiazole-tetrahydropyran triazole-linked hybrids with selective antiproliferative activity against human tumour cells
Guillermo Valdomir (2018)
A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer
Jia Hua-feng (2018)
Phytochemical and antimicrobial study of Pilocarpus pennatifolius Lemaire.
Gabriele do Carmo (2018)
Catalyst-free three-component approach to efficient synthesis of chromeno[4,3-b]pyrrol-4(1H)-one derivatives
X. Yang (2018)
Synthesis, Characterization, and Cytotoxicity Evaluation of Some New Benzo[f]coumarin Derivatives
K. Mohamed (2018)
7-Isopenthenyloxycoumarin, Arctigenin, and Hesperidin Modify Myeloid Cell Leukemia Type-1 (Mcl-1) Gene Expression by Hormesis in K562 Cell Line
Zahra Kafi (2018)
Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin
Li Qin (2018)
The Effects of Synthetically Modified Natural Compounds on ABC Transporters
Daniel D. E. Dantzic (2018)
Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
N. Lv (2017)See more